Abstract This is a short preface of this Special Issue Lactoferrin, it described the major points of key reporters in ' In the most recent conference with a size of over 130 attendees from 23 countries and regions, scientists gave a total 45 oral presentations including the following topics: structure-function relationships, ligands/receptors, regulation of cell proliferation and differentiation, immunomodulating effects, Lf in pathologies, antimicrobial activity of Lf and Lfderivatives, molecular design and expression of Lfderivatives, recombinant and transgenic Lfs and applications. In addition, safety evaluation, policy and legislation of transgenic Lf research, molecular design and expression of antimicrobial Lf-derived poplypeptides, Lf evaluation and quality assays were also deeply discussed.
Lactoferrin (Lf) is an extracellular iron binding glycoprotein that was first identified in milk secretions and functions as a key component of the mammalian immune defense. 'The International Conference on Lf Structure, Function and Applications' is held biennially and allows scientists to introduce and discuss the latest research advances related to this fascinating glycoprotein and its potential applications. This BioMetals special issue on Lactoferrin contains refereed papers from most of the speakers at the IXth International Lactoferrin Conference held during 18-22nd October 2009 at Beijing (China) and organized by the Feed Research Institute, the Chinese Academy of Agricultural Sciences. The co-organizers include the Chinese Academy of Agricultural Sciences, Friesland Foods Domo/ DMV, the National Natural Science Foundation of China, the Natural Science Foundation of Beijing, Shanghai Genon Bio-engineering Co. Ltd./Shanghai Transgenic Research Center, and the State Key Laboratory for Agrobiotechnology of China Agricultural University.
In the most recent conference with a size of over 130 attendees from 23 countries and regions, scientists gave a total 45 oral presentations including the following topics: structure-function relationships, ligands/receptors, regulation of cell proliferation and differentiation, immunomodulating effects, Lf in pathologies, antimicrobial activity of Lf and Lfderivatives, molecular design and expression of Lfderivatives, recombinant and transgenic Lfs and applications. In addition, safety evaluation, policy and legislation of transgenic Lf research, molecular design and expression of antimicrobial Lf-derived poplypeptides, Lf evaluation and quality assays were also deeply discussed.
The sequence and structural features of Lf underpin its functional attributes. Professor Baker introduced the latest research on the three-dimensional structure of Lf and the importance of surface features, discussed the iron binding sites and conformational transitions between iron-bound and iron-free forms. Professor Lonnerdal has recently found that the posttranscriptional expression of the Lf receptor is regulated by a specific microRNA miRNA-584. Lf was also found to stimulate cell proliferation with apo-Lf stimulating to a greater extent than holo-Lf. Professor Schryvers discussed the functional domains of the bacterial Lf binding proteins A and B (LbpA and LbpB), which enable Lf to be utilized as a source of iron for several Gram-negative bacterial pathogens of humans. Professor Pierce introduced delta-Lf, a 73 kDa cytoplasmic isoform of Lf, which is a transcription factor that regulates cell survival. Prof essor Choi demonstrated that a relatively low level of iron saturated Lf can elevate the level of cyclin D1 and stimulate S phase cell cycle entry.
There is a growing interest in the potential use of Lf for the improvement of bone health. Professor Cornish researched the mechanism and found that the mitogenic effect of Lf in osteoblasts is mediated mainly through a member of the low density lipoprotein receptor-related proteins (LRP1). Lf is a key component of the first line of host defenses. Professor Legrand reviewed the process and mechanism of iron-chelating anti-microbial activity and anti-inflammatory activity in fluids. Professor Valenti's research showed that oral administration of bovine Lf (bLf) resulted in beneficial effects including a mean increase of red blood cells, hemoglobin, total serum iron and serum ferritin that was significantly higher with respect to oral administration of ferrous sulfate. It was concluded that in hereditary thrombophilia affecting pregnant women, oral administration of bLf exerts a potent effect to cure iron deficiency and iron deficiency anemia and to decrease serum interleukin-6, one of the key factors in iron homeostasis and coagulation disorders. Professor Teng reviewed the basics of transcriptional regulation at different levels, Lf gene organization, methylation of the Lf gene and the signaling pathways that regulate the Lf gene expression.
The development of transgenic animals was considered to be the approach with the greatest potential for large scale production of Lf for industrial purposes. Ms Gros-Van Hest discussed the safety evaluation of recombinant human Lf (rhLf) and rhLF products with different purities by transgenic cows. Professor Li described four transgenic cows that secreted rhLf at a level of 3.4 g/l. In the milk, Lf provides protection against bacterial contamination. Professor Perraudin stated that during the production of the Lf, the process of elimination of lipopolysaccharide bound to Lf is crucial before it reaches the market.
The peptides lactoferricin (LFcin), LFB15 (W4, 10) and lactoferrampin (LFampin), derived from the Lf N-lobe, have higher antimicrobial activity than the intact Lf. Dr Yang presented research about the molecular design of the novel antimicrobial peptide LH28, derived from peptide LFB15 (W4, 10). Both LH28 and LFampin were heterologously expressed and characterized in the Escherichia coli system. Research by Dr Nidia found that the Lf chimera, Lf, LFcin and LFampin have potential as bactericidal agents against antibiotic-resistant Staphylococcus aureus and Escherichia coli. Moreover, the Lf chimera, LFcin and LFampin exhibited a microbicidal effect against the parasite Entamoeba histolytica.
Finally, Professor Shimazaki described a preliminary approach to creating an overview of Lf multifunctionality utilizing a text mining method. Such information visualization analysis will be very useful in determining novel relationships among a multitude of Lf functions and mechanisms.
The Spik Award was instituted in recognition of one of the pioneers in the Lf field, Professor Genevieve Spik of the University of Lille, France. This award recognizes young scientists with outstanding achievements. Stephan Hardiville was selected for the award this year from a group of eight excellent student candidates. There is an increasing interest by companies in the in-depth exploration of the functions and applications of Lf presented at the conference. We sincerely appreciate the financial support provided by the sponsors: Shanghai Genon Bio-engineering Co. Ltd. (Shanghai Transgenic Research Center), Friesland Foods Domo/ DMV, Morinaga Co. Ltd., Taradon Laboratory, Pharming Group N.V., TATUA Co-operative Dairy Co., Pall-Food and Beverage, Westland Milk Products, NRL Pharma Inc., Belgomilk, Favea, and New Baili International Industry & Trade Co. Ltd. Their financial support was invaluable for organizing the meeting and supporting the attendance of participating students and scientists.
This special issue consists of over 20 reviews and research papers, from which the readers can browse a different panaroma of lactoferrin research and development during past two years with more detail information than the oral talk or poster presentations at the conference. For example, Pietrantoni et al. observed an inhibition of bovine lactoferrin against programmed cell death in vitro induced by influenza a virus. A possible interaction between bovine lactoferrin and cable pili of Burkholderia cenocepacia was revealed (Ammendolia et al.) . The liposomalization was considered to enhance anti-tumoral effects of lactoferrin on melanoma cells (Roseanua et al.) . A potential contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus was deduced (Bai et al.) . Takayama et al. put forward that lactoferrin regulates chondrogenic differentiation by up-regulating the Smad2/3-Sox9 signaling pathway of mouse ATDC5 chondroprogenitor cells. Hoedt et al. for the first time developed an assay using TaqMan real time PCR to discriminate and evaluate gene expression levels of lactoferrin and deltalactoferrin in cancer cells and cells under inflammatory stimuli. A study about probiotic Lactobacillus casei expressing human lactoferrin for the purpose of higher antibacterial activity in host gastrointestinal tract would attract more attention (Chen et al.) . van der Does et al. reported that a human lactoferrinderived peptide (hLF1-11) primes monocytes of human and murine so that upon encountering microbial stimuli the cells produce enhanced levels of proinflammatory and anti-inflammatory cytokines and chemokines. In addition, some papers (Wakabayashi et al., Evrard et al., Héctor et al., and Tian et al.) focusing on application in the field of food and pharmacetical industry related to lactoferrin would also attract your attentions. As for those their papers with a similar subject as their oral reports mentioned in above paragraphs will not be repeated here.
We are very happy that the IXth International Lactoferrin Conference was successfully implemented according to the original plans. We sincerely thank all our colleagues who have made a contribution to this special issue for Lf and especially to the editorial staff of BioMetals.
The Xth Lf conference will be held in Sinaloa, Mexico in 2011. We wish the organizers great success in the next meeting and hope that more colleagues can gather in sunny and beautiful Mexico.
